Clinical Trials Browser

Phase 1 × Refractory Solid Tumors × Erlotinib Hydrochloride × Clear all

NCT00759928 2014-07-02

PK Trial of Sorafenib & Erlotinib in Patients With Refractory Solid Tumors

Phase 1 Completed

Other solid neoplasm

Refractory Solid Tumors